Medicine injector
Latest Novartis AG Patents:
- Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodies
- Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
- CD19 and CD22 chimeric antigen receptors and uses thereof
- Treatment of cancer using GFR alpha-4 chimeric antigen receptor
- Tricyclic AKR1C3 dependent KARS inhibitors
Description
The broken lines shown in
Claims
The ornamental design for a medicine injector, as shown and described.
Patent History
Patent number: D677381
Type: Grant
Filed: Jun 12, 2012
Date of Patent: Mar 5, 2013
Assignee: Novartis AG (Basel)
Inventors: Nicholas Charles Stones (Basel), Martin James Dinnage (Cambridge), Serge Roux (Cambridge, MA), Jeremy Alan Van Hill (Boston, MA), Timothy Duncan Wooller (London), Andy Duncan Pidgeon (Cambridge), Alan Leslie Hawkins (Kent)
Primary Examiner: David Muller
Application Number: 29/424,442
Type: Grant
Filed: Jun 12, 2012
Date of Patent: Mar 5, 2013
Assignee: Novartis AG (Basel)
Inventors: Nicholas Charles Stones (Basel), Martin James Dinnage (Cambridge), Serge Roux (Cambridge, MA), Jeremy Alan Van Hill (Boston, MA), Timothy Duncan Wooller (London), Andy Duncan Pidgeon (Cambridge), Alan Leslie Hawkins (Kent)
Primary Examiner: David Muller
Application Number: 29/424,442
Classifications
Current U.S. Class:
Hand Actuated Flow Control (e.g., Lever, Button, Etc.) (D24/113)